Envista Holdings CorpNVST
What Envista Holdings Corp does.
Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. We help our customers deliver the best possible patient care through industry-leading products, solutions, and technology. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the human smile. We further support the dental community with leading solutions in restoratives, endodontics, rotary, infection prevention, and loupes.
We were formed in 2018 as a wholly-owned subsidiary of Danaher Corporation. In 2019, we completed our initial public offering and separated from Danaher Corporation.
With a foundation comprised of the proven Envista Business System (“EBS”) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, we are well equipped to meet the end-to-end needs of dental professionals worldwide. We are one of the largest global dental products companies, with strong positions in some of the most attractive segments of the dental products industry. We serve dental professionals in over 130 countries through one of the largest commercial organizations in the dental products industry and through our distribution partners. In 2025, we generated total sales of $2.7 billion, of which approximately 85% were derived from sales of consumable products, services, and spare parts.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.9B | $2.5B | $2.6B | $2.6B | $2.5B | $2.7B |
| Net income | $33.3M | $340.5M | $243.1M | -$100.2M | -$1.1B | $47.0M |
| Free cash flow | $236.2M | $306.9M | $107.0M | $217.5M | $302.7M | $230.4M |
More on NVST.
- Envista Holdings Corp summary
- Envista Holdings Corp financial statements
- Envista Holdings Corp key metrics
- Envista Holdings Corp health scores and style box
- Envista Holdings Corp earnings
- Envista Holdings Corp dividends
- Envista Holdings Corp valuation
- Envista Holdings Corp ownership and insiders
- Envista Holdings Corp peers
Figures from Envista Holdings Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.